List of 99 formulations
| -- | NATIONAL LIST OF ESSENTIAL MEDICINES 2011 | |||||
|---|---|---|---|---|---|---|
-- |
Section: 1 – Anesthesia | -- |
||||
-- |
1.1 General Anesthetics and Oxygen | -- |
||||
-- |
Sl. No. | Medicines | Category | Route of Administration | Strengths | -- |
-- |
1 | Ether | S, T | Inhalation | — | -- |
-- |
2 | Ketamine Hydrochloride | P, S, T | Injection | 10 mg / ml | -- |
-- |
1.2 Local Anesthetics | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
3 | Lignocaine Hydrochloride | P, S, T | Spinal | 5% +7.5% Glucose | -- |
-- |
1.3 Preoperative Medication and Sedation for Short Term Procedures | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
4 | Diazepam | S, T | Syrup | 2mg/5ml | -- |
-- |
5 | Diazepam | Suppository | 5 mg | -- |
|
-- |
Section: 2 – Analgesics , Antipyretics, Nonsteroidal Anti-inflammatory Medicines, Medicines used to treat Gout and Disease Modifying Agents used in Rheumatoid Disorders | -- |
||||
-- |
2.2 Opioid Analgesics | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
6 | Tramadol | -- |
Cap | 100 mg | -- |
-- |
Section: 4 – Antidotes and Other Substances used in Poisonings | |||||
-- |
4.1: Nonspecific | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
7 | Activated Charcoal | P,S,T | Oral | -- |
-- |
-- |
4.2: Specific | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
8 | Atropine Sulphate | P,S,T | Injection | 1 mg/ml | -- |
-- |
9 | Methylthioninium chloride (Methylene blue) | S, T | Injection | 10 mg / ml | -- |
-- |
10 | Penicillamine | S, T | Tablets or Capsules | 250 mg | 13.12 |
-- |
11 | Dimercaprol | S, T | Injection in oil | 50 mg / ml | -- |
-- |
12 | Flumazenil | T | Injection | 0.1 mg / ml | -- |
-- |
13 | Sodium Nitrite | S, T | Injection | 30 mg / ml | -- |
-- |
14 | Sodium Thiosulphate | S, T | Injection | 250 mg/ ml | -- |
-- |
15 | Pralidoxime Chloride(2-PAM) | P,S,T | Injection | 25 mg/ml | -- |
-- |
Section: 5 – Anticonvulsants/ Antiepileptics | -- |
||||
-- |
16 | Phenytoin Sodium | P,S,T | Injection | 25 mg/ml | -- |
-- |
17 | Sodium Valproate | P,S,T | Syrup | 500mg | 0.58 |
-- |
Section: 6 – Anti-infective Medicines | -- |
||||
-- |
6.1 Anthelminthics | |||||
-- |
6.1.1 Intestinal Anthelminthics | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
Added Medicines | |||||
-- |
18 | Piperazine | P,S,T | Tablets | 4.5 gm | -- |
-- |
19 | Solution | 750mg/5ml | 0.38 | ||
-- |
6.2 Antibacterials | |||||
-- |
6.2.4 Antituberculosis medicines | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
20 | Isoniazid | P,S,T | Tablets | 50 mg | -- |
-- |
6.3 Antifungal medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
21 | Nystatin | P,S,T | Tablets | 500,000 IU | -- |
-- |
22 | Nystatin | P,S,T | Pessaries | 100,000 IU | -- |
-- |
6.4.2 Antiretroviral medicines | -- |
||||
-- |
6.4.2.1 Nucleoside reverse transcriptase inhibitors | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
23 | Stavudine | S, T | Capsules | 15 mg | -- |
-- |
24 | Didanosine | S, T | Tablets | 400 mg | -- |
-- |
6.4.2.2 Non-nucleoside reverse transcriptase inhibitors | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
25 | Efavirenz | S,T | Capsules | 600 mg | -- |
-- |
26 | Nevirapine | S, T | Capsules | 200 mg | -- |
-- |
27 | Indinavir | S, T | Capsules | 200 mg | -- |
-- |
28 | Nelfinavir | S, T | Capsules | 250 mg | -- |
-- |
29 | Ritonavir | S, T | Syrup | 400 mg / 5ml | -- |
-- |
30 | Saquinavir | S, T | Capsules | 200 mg | -- |
-- |
6.5.3.1 For curative treatment | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
31 | Pyrimethamine | P,S,T | Tablets | 25 mg | -- |
-- |
32 | Clindamycin | S,T | Tablet | 150mg | -- |
| 6.5.4 Antipneumocystosis and Antitoxoplasmosis medicines | -- |
|||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
33 | Pentamidine Isothionate | S, T | Injection | 200 mg | -- |
-- |
Section: 8 – Antineoplastic, immunosuppressives and medicines used in palliative care | -- |
||||
-- |
8.1: Immunosuppressive medicines | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
34 | Cyclosporine | T | Capsules | 10 mg | -- |
-- |
8.2: Cytotoxic medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
35 | Actinomycin D | T | Injection | 0.5 mg | -- |
-- |
36 | Cyclophosphamide | T | Tablets | 200 mg | -- |
-- |
37 | Mercaptopurine | T | Injection | 100 mg / ml | -- |
-- |
Section: 10 –Medicines affecting the blood | -- |
||||
-- |
10.1: Antianaemia medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
38 | Ferrous Sulphate/Fumrate | P,S,T | Tablets | Tablets equivalent to 60 mg elemental iron | -- |
-- |
39 | Ferrous Sulphate/Fumrate | P,S,T | Oral solution | 25mg elemental iron (as sulphate)/ml | -- |
-- |
40 | Pyridoxine | P,S,T | Tablets | 10 mg | -- |
-- |
Section: 11 –Blood products and Plasma substitutes | -- |
||||
-- |
11.1: Plasma Substitutes | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
41 | Dextran-70 | P,S,T | Injection | 6% | -- |
-- |
Section: 11 –Blood products and Plasma substitutes | |||||
-- |
11.1: Plasma Substitutes | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
42 | Fresh frozen plasma | T | Injection | -- |
-- |
-- |
43 | Polygeline | S, T | Injection | 3.50% | -- |
-- |
11.2: Plasma fractions for specific use | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
44 | Cryoprecipitate | S, T | Injection | -- |
-- |
-- |
45 | Factor IX Complex (Coagulation Factors II,VII, IX, X) | S, T | Injection | Dried | -- |
-- |
46 | Platelet Rich Plasma | S, T | Injection | -- |
-- |
-- |
Section: 12 –Cardiovascular medicines | -- |
||||
-- |
12.2: Antiarrhythmic medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
47 | Procainamide Hydrochloride | T | Tablets | 250 mg | -- |
-- |
12.4: Medicines used in heart failure | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
48 | Digoxin | S, T | Elixir | 0.05 mg/ml | -- |
-- |
12.5: Antithrombotic medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
49 | Urokinase | T | Injection | 500,000 IU/ml | -- |
-- |
Section: 13 –Dermatological medicines (Topical) | -- |
||||
-- |
13.1: Antifungal medicines | |||||
-- |
50 | Neomycin + Bacitracin | P,S,T | Ointment | 5 mg + 500 IU / g | -- |
-- |
13.2: Antiinfective medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
51 | Methylrosanilinium Chloride (Gentian Violet) | P,S,T | Aqueous solution | 0.50% | -- |
-- |
13.4: Astringent Medicines | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
52 | Zinc Oxide | P,S,T | Dusting Powder | -- |
-- |
-- |
13.5: Medicines affecting skin differentiation and proliferation | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
53 | Coal Tar | P,S,T | Solution | 5% | -- |
-- |
54 | Salicylic Acid | P,S,T | Solution | 5% | -- |
-- |
Section: 14 –Diagnostic agents | -- |
||||
-- |
14.1: Ophthalmic medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
55 | Lignocaine | S, T | Eye Drops | 4% | -- |
-- |
56 | Fluorescein | S, T | Eye drops | 1% | -- |
-- |
14.2: Radiocontrast media | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
57 | Barium Sulphate | S, T | Suspension | 100% w/v | -- |
-- |
58 | Barium Sulphate | 250% w/v | -- |
||
-- |
59 | Calcium Ipodate | S, T | Injection | 3 g | -- |
-- |
60 | Iopanoic Acid | S, T | Tablets | 500 mg | -- |
-- |
61 | Meglumine Iothalamate | S, T | Injection | 60% w/v (iodine =280 mg / ml) | -- |
-- |
62 | Meglumine Iotroxate | S, T | Solution | 5-8 g iodine in 100-250 ml | -- |
-- |
63 | Propyliodone | S, T | Oily, suspension | 500-600 mg / ml | -- |
-- |
64 | Sodium Meglumine Diatrizoate | S, T | Injection | 60% w/v(Iodine conc. =292 mg / ml) | -- |
-- |
65 | Sodium Meglumine Diatrizoate | 76% w/v(Iodine conc. =370 mg / ml) | -- |
||
-- |
66 | Sodium Meglumine Diatrizoate | S, T | Injection | 60% w/v(Iodine conc. =292 mg / ml) | -- |
-- |
Section: 15 –Disinfectants and antiseptics | -- |
||||
-- |
15.1: Antiseptics | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
67 | Chlorhexidine | P, S, T | Solution | 5% (conc. for dilution) | -- |
-- |
68 | Gentian Violet | P, S, T | Paint | 0.50% | -- |
-- |
69 | Acriflavin+Glycerin | P, S, T | Solution | -- |
-- |
-- |
15.2: Disinfectants | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
70 | Bleaching Powder | P, S, T | Powder | Contains not less than 30 % w/w of available chlorine (as per I.P) | -- |
-- |
71 | Formaldehyde Solution | P, S, T | Solution | Dilute 34 ml of formaldehyde solution with water to produce 100 ml (As per I.P) | -- |
-- |
Section: 16 –Diuretics | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
72 | Hydrochlorothiazide | P,S,T | Tablets | 50 mg | -- |
-- |
Section: 17 – Gastrointestinal medicines | -- |
||||
-- |
17.4: Antispasmodic medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
73 | Dicyclomine Hydrochloride | P,S,T | Tablets | 10 mg | -- |
-- |
Section: 17 – Gastrointestinal medicines | |||||
-- |
17.6.2 Antidiarrhoeal medicines | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
Medicines added | |||||
-- |
74 | Zinc Sulfate | P,S,T | Syrup | 20 mg/5ml | -- |
-- |
Section: 18 –Hormones, other endocrine medicines and contraceptives | -- |
||||
-- |
18.3: Contraceptives | -- |
||||
-- |
18.3.1: Hormonal Contraceptives | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
75 | Ethinylestradiol + Norethisterone | P,S,T | Tablets | 0.035 mg +1.0 mg | -- |
-- |
76 | Hormone Releasing IUD | T | Levonorgesterol Releasing | IUD | -- |
-- |
18.8 Thyroid and antithyroid medicines | |||||
-- |
-- |
Medicines | Category | Route of Administration / Dosage Form | Strengths | -- |
-- |
77 | Iodine | S,T | Solution | 8 mg / 5 ml | -- |
-- |
Section: 19 Immunologicals | |||||
-- |
19.1: Diagnostic agents | |||||
-- |
-- |
Drugs | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
78 | Tuberculin, Purified Protein derivative | P,S,T | Injection | 1 TU | -- |
-- |
79 | Tuberculin, Purified Protein derivative | 5 TU | -- |
||
-- |
Section: 20 – Muscle Relaxants (Peripherally acting) and Cholinesterase Inhibitors | -- |
||||
-- |
-- |
Drugs | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
80 | Pyridostigmine | S, T | Injection | 1mg/ml | -- |
-- |
Section: 21 – Ophthalmological Preparations | -- |
||||
-- |
21.1: Anti-infective agents | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
81 | Chloramphenicol | P,S,T | Drops | 0.40% | 43 |
-- |
82 | Chloramphenicol | P,S,T | Ointment | 0.40% | 44 |
-- |
83 | Miconazole | P,S,T | Drops | 1% | -- |
-- |
84 | Povidone Iodine | S,T | Drops | 0.60% | -- |
-- |
21.3: Local Anaesthetics | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
85 | Tetracaine Hydrochloride | P,S,T | Drops | 0.50% | -- |
-- |
21.4: Miotics and Antiglucoma medicines | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
86 | Pilocarpine | S,T | Drops | 4% | -- |
-- |
21.5: Mydriatics | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
87 | Phenylephrine | P,S,T | Drops | 5% | -- |
-- |
Section: 25 – Medicines acting on the respiratory tract | -- |
||||
-- |
25.2: Antitussives | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
88 | Codeine phosphate | S,T | Tablets | 10mg | -- |
-- |
89 | Codeine phosphate | -- |
Syrup | 15mg/ 5ml | 42 |
-- |
90 | Dextromethorphan | P,S,T | Tablets | 30mg | -- |
-- |
Section: 26 – Solutions correcting water, electrolyte and acid-base disturbances | -- |
||||
-- |
26.2: Parenteral | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
91 | Glucose | P, S, T | Injection | 15% | -- |
-- |
92 | N/2 Saline | S, T | Injection | -- |
-- |
-- |
93 | N/5 Saline | S, T | Injection | -- |
-- |
-- |
94 | Potassium Chloride | P, S, T | Injection | 11.2% Sol. | -- |
-- |
26.3: Miscellaneous | |||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
95 | Water for Injection | P, S, T | Injection | 2 ml | -- |
-- |
Section: 27 – Vitamins and Minerals | -- |
||||
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
96 | Pyridoxine | P,S,T | Tablets | 25 mg | -- |
-- |
-- |
Medicines | Category | Route of Administration/ Dosage Form | Strengths | -- |
-- |
97 | Nicotinamide | P,S,T | Tablets | 50 mg | -- |
-- |
98 | Vitamin D (Ergocalciferol) | P,S,T | Capsules | 0.25 mg | -- |
-- |
99 | Vitamin D (Ergocalciferol) | Capsules | 1 mg | -- |
|
Last Page Updated: 22-01-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)